Healthcare / Medical Care FacilitiesLSE
$1233.00
-18.00 (-1.44%)
FCF base 3Y
n/d
n/d CAGR · yield n/d
FCF base 5Y
n/d
n/d base · n/d expected
Precio de entrada
n/d
MOS 23% · confianza 25%
FCF escenarios
weak_data · normalized FCF $38.8M · quality 70.0/100
Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.
SA Score
34/100
D
Piotroski
3/9
balance/quality
Valuation
50/100
+0.0% upside
5Y CAGR
+0.0%
50/100
Data QA
16/100
SEC 0%
Sin guardar todavía.
Market Cap
$863M
P/E
53.6x
↑EV/EBITDA
840.8x
↑ROE
2.5%
↑Gross Margin
42.1%
↓Debt/Equity
1.11
↑TradingView lightweight chart
Absolute Values (Left Axis)
Ratios / Percentages (Right Axis)
Financial statement dashboard
2021–2024 · 3 años de histórico normalizado
Revenue CAGR
+7.8%
FCF CAGR
-17.3%
FCF margin
3.9%
FCF / Net income
3.86x
Latest source
Provider fallback
Margin decomposition
Último año: revenue $638.7M · net income $6.4M · FCF $24.7M
Gross margin
Operating margin
Net margin
FCF margin
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | $638.7M | $638.7M | $588.9M | $554.2M | $510.1M |
| Net Income | $6.4M | $6.4M | $41.9M | $25.7M | $19.3M |
| EBITDA | $105.4M | $105.4M | $117.8M | $90.0M | $87.8M |
| EPS | 0.09 | 0.09 | 0.58 | 0.36 | 0.27 |
| Gross Margin | 42.1% | 42.1% | 43.8% | 43.1% | 43.5% |
| Operating Margin | 7.5% | 7.5% | 11.6% | 7.7% | 7.9% |
| Net Margin | 1.0% | 1.0% | 7.1% | 4.6% | 3.8% |
| Balance Sheet | |||||
| Debt/Equity | 1.11 | 1.11 | 0.77 | 0.87 | 0.96 |
| Current Ratio | 1.07 | 1.07 | — | — | — |
| Cash Flow | |||||
| Free Cash Flow | $24.7M | $24.7M | $38.8M | $51.0M | $43.6M |
| Returns | |||||
| ROE | 2.5% | 2.5% | 16.3% | 11.8% | 10.1% |
| Valuation | |||||
| P/E | 53.61 | 53.61 | 3251.28 | 4537.60 | 8763.84 |
| EV/EBITDA | 840.84 | 840.84 | 1158.41 | 1296.65 | 1926.85 |
| P/B | 339.30 | 339.30 | 530.28 | 536.15 | 884.50 |
| Growth & Yield | |||||
| Revenue Growth | 8.5% | 8.5% | 6.3% | 8.6% | — |
| EPS Growth | -85.3% | -85.3% | 63.0% | 32.5% | — |
| Dividend Yield | 0.7% | 0.7% | — | — | — |
Revenue, Net Income & Free Cash Flow ($B)
Margins (%)
Returns (%)
Leverage & Liquidity
3Y implied EPS CAGR
983.6%
EPS terminal req.
$109.41
Spread vs growth
-1068.9%
5Y implied EPS CAGR
334.0%
EPS terminal req.
$132.38
Spread vs growth
-419.3%
10Y implied EPS CAGR
118.5%
EPS terminal req.
$213.21
Spread vs growth
-203.8%
Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.
Total return
-0.8%
Start / end P/E
2140.2x → 14337.2x
EPS bridge
0.58 → 0.09
Residual
-486.1%
Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.